<DOC>
	<DOCNO>NCT01891318</DOCNO>
	<brief_summary>This Phase I/II trial study ability stop brain metastasis come back treatment radiosurgery follow surgical resection . It also evaluate side effect combine treatment help determine best radiosurgery dose . Radiosurgery focus x-ray directly tumor cause less damage normal tissue brain .</brief_summary>
	<brief_title>Neoadjuvant Radiosurgery Resectable Brain Metastases : Phase I/II Study</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine safety ( risk acute long-term toxicity ) neoadjuvant radiosurgery escalating dos follow surgical resection brain metastasis . ( Phase I ) II . To determine local control brain metastasis treat neoadjuvant radiosurgery follow surgical resection . ( Phase II ) SECONDARY OBJECTIVES : I . To determine rate distant brain failure brain metastasis manage neoadjuvant radiosurgery follow surgical resection . II . To estimate rate salvage surgery , whole brain radiation therapy ( WBRT ) , stereotactic radiosurgery ( SRS ) patient treat neoadjuvant radiosurgery follow surgical resection . III . To estimate neurocognitive outcome patient treat neoadjuvant radiosurgery follow surgical resection . IV . To determine rate radiation necrosis/steroid dependency . V. To estimate quality life patient treat neoadjuvant radiosurgery follow surgical resection . VI . To determine radiobiologic impact neoadjuvant radiosurgery resect brain metastasis . OUTLINE : This phase I , dose-escalation study radiosurgery follow phase II study . Patients undergo radiosurgery day 0 . Within 2 week , patient undergo surgical resection . After completion study treatment , patient follow 1 , 3 , 6 , 9 , 12 month .</detailed_description>
	<criteria>Have prior histologic diagnosis cancer small cell lung cancer , lymphoma , germ cell histology Magnetic resonance imaging ( MRI ) evidence 14 brain metastasis , least one lesion &gt; 20 mm ≤ 50 mm maximal diameter determine appropriate SRS gross total resection ; brain metastasis appropriate SRS Patient prior SRS lesion one plan neoadjuvant SRS resection Patient must Karnofsky performance score ≥ 70 Patient deem medically unfit undergo surgical resection brain metastasis Prior whole brain radiotherapy Patient contraindication image MRI Inability participate study activity due physical mental limitation Inability unwillingness return require followup visit At time planning , unable deliver 10 Gray ( Gy ) less optic nerve/chiasm Tumor locate brainstem Imaging cytologic evidence leptomeningeal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>